Harvard Profs Battle Over $1.5B Antitrust Damages Estimate
A Harvard University professor emeritus testifying in a federal antitrust trial Friday over claims Gilead and Teva illegally delayed generic versions of HIV medications told a California jury that the suit's...To view the full article, register now.
Already a subscriber? Click here to view full article